中性粒细胞的不良功能受到免疫复合体介导的新月球球球膜炎中性粒细胞血管酶转化酶的调节
Suguru Saito1,2, Satoshi Kumakura3, Zakir Khan4
1Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, United States.
American journal of physiology. Renal physiology
|June 17, 2025
概括
中性粒细胞可以伤害或保护脏在质核突炎. 过度表达中性粒细胞中的血管酶转化酶 (ACE) 提供脏保护,需要ACE域和补充C3.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 中性粒细胞有助于免疫复杂介导的新月状球膜炎 (GN) 的损伤.
- ангиотензин转化酶 (ACE) 调节血压和炎症.
- 之前的研究表明,ACE过度表达的中性粒细胞通过补充C3b-补充受体1/2轴对GN进行保护.
研究的目的:
- 阐明中性粒细胞在GN中的致病性和保护性作用背后的精确机制.
- 研究ACE域的特定作用,并补充C3在中性友的保护.
主要方法:
- 在四个条件下在小鼠中诱导毒性血清炎 (NTN):中性粒细胞枯竭,采用 ACE 过度表达的中性粒细胞的转移,分析 ACE 域淘汰赛小鼠,并补充 C3 淘汰赛小鼠与中性粒细胞 ACE 过度表达.
- 评估淋巴细胞损伤和脏保护作用.
主要成果:
- 中性细胞枯竭在过度表达ACE的中性细胞小鼠中恶化了损伤,而这些细胞的转移在野生型小鼠中改善了损伤.
- 对于ACE的C和N域都是必要的,以实现完全的保护.
- 补充C3对于中性爱性ACE的保护功能至关重要.
结论:
- 中性粒细胞在GN中表现出致病性和非正规的脏保护功能.
- 中性爱性ACE的保护作用通过其C和N域进行介导,并依赖于补充C3.
- 针对中性友好的ACE可能为GN提供一种新的治疗策略.
更多相关视频
11:32Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists
Published on: October 18, 2024
728
09:59A High-throughput Assay to Assess and Quantify Neutrophil Extracellular Trap Formation
Published on: January 29, 2019
10.2K
相关概念视频
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
913
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
913
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
526
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
526
01:29Acute Kidney Injury II: Pathophysiology
101
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
101
01:25Antihypertensive Drugs: Direct Renin Inhibitors
849
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
849
01:28Glomerular Filtration Rate and its Regulation
3.4K
The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
3.4K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
950
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
950